Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cancer. Encouraging results for second-generation antiangiogenesis drugs.

× No keyword cloud information.

14 in total

1. A DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growth.

Authors: Lars Holmgren; Elena Ambrosino; Olivier Birot; Carl Tullus; Niina Veitonmäki; Tetyana Levchenko; Lena-Maria Carlson; Piero Musiani; Manuela Iezzi; Claudia Curcio; Guido Forni; Federica Cavallo; Rolf Kiessling
Journal: Proc Natl Acad Sci U S A Date: 2006-06-05 Impact factor: 11.205

2. Combinatorial protein therapy of angiogenic and arteriogenic factors remarkably improves collaterogenesis and cardiac function in pigs.

Authors: Huixia Lu; Xinsheng Xu; Mei Zhang; Renhai Cao; Ebba Bråkenhielm; Changjiang Li; Huili Lin; Guihua Yao; Huiwen Sun; Lihang Qi; Mengxiong Tang; Hongyan Dai; Yanen Zhang; Runyi Su; Yanwen Bi; Yun Zhang; Yihai Cao
Journal: Proc Natl Acad Sci U S A Date: 2007-07-16 Impact factor: 11.205

3. Anti-tumor angiogenesis effect of genetic fusion vaccine encoding murine beta-defensin 2 and tumor endothelial marker-8 in a CT-26 murine colorectal carcinoma model.

Authors: Ping Liu; Ganfeng Xie; Peiliang Geng; Chenhong Zheng; Jianjun Li; Feng Pan; Zhihua Ruan; Houjie Liang
Journal: Int J Clin Exp Med Date: 2015-03-15

4. Repeated tumor oximetry to identify therapeutic window during metronomic cyclophosphamide treatment of 9L gliomas.

Authors: Sriram Mupparaju; Huagang Hou; Jean P Lariviere; Harold Swartz; Youssef Jounaidi; Nadeem Khan
Journal: Oncol Rep Date: 2011-04-15 Impact factor: 3.906

5. Effect of pazopanib on tumor microenvironment and liposome delivery.

Authors: Tina D Tailor; Gabi Hanna; Pavel S Yarmolenko; Matthew R Dreher; Allison S Betof; Andrew B Nixon; Ivan Spasojevic; Mark W Dewhirst
Journal: Mol Cancer Ther Date: 2010-06-01 Impact factor: 6.261

6. The small-molecule VEGF receptor inhibitor pazopanib (GW786034B) targets both tumor and endothelial cells in multiple myeloma.

Authors: Klaus Podar; Giovanni Tonon; Martin Sattler; Yu-Tzu Tai; Steven Legouill; Hiroshi Yasui; Kenji Ishitsuka; Shaji Kumar; Rakesh Kumar; Lini N Pandite; Teru Hideshima; Dharminder Chauhan; Kenneth C Anderson
Journal: Proc Natl Acad Sci U S A Date: 2006-12-12 Impact factor: 11.205

7. Combined analysis of transcriptome and proteome data as a tool for the identification of candidate biomarkers in renal cell carcinoma.

Authors: Barbara Seliger; Sven P Dressler; Ena Wang; Roland Kellner; Christian V Recktenwald; Friedrich Lottspeich; Francesco M Marincola; Maja Baumgärtner; Derek Atkins; Rudolf Lichtenfels
Journal: Proteomics Date: 2009-03 Impact factor: 3.984

8. Targeting c-KIT, PDGFR in cancer of unknown primary: a screening study for molecular markers of benefit.

Authors: L Dova; G Pentheroudakis; V Golfinopoulos; V Malamou-Mitsi; I Georgiou; G Vartholomatos; A Ntemou; G Fountzilas; N Pavlidis
Journal: J Cancer Res Clin Oncol Date: 2007-12-07 Impact factor: 4.553

9. Increased tumor oxygenation and drug uptake during anti-angiogenic weekly low dose cyclophosphamide enhances the anti-tumor effect of weekly tirapazamine.

Authors: J C Doloff; N Khan; J Ma; E Demidenko; H M Swartz; Y Jounaidi
Journal: Curr Cancer Drug Targets Date: 2009-09 Impact factor: 3.428

10. Highly potent VEGF-A-antagonistic DARPins as anti-angiogenic agents for topical and intravitreal applications.

Authors: Andreas Stahl; Michael T Stumpp; Anja Schlegel; Savira Ekawardhani; Christina Lehrling; Gottfried Martin; Maya Gulotti-Georgieva; Denis Villemagne; Patrik Forrer; Hansjürgen T Agostini; H Kaspar Binz
Journal: Angiogenesis Date: 2012-09-15 Impact factor: 9.596